Spreadsheet: 113931d1309821492-compare-data-in-multiple-columns-to-find-duplicates-and-conditionally-highlight-mrexcel-example-highlight-duplicates-across-multiple-columns
Sheet: Targets

[NAME] (Pseudonym) | Full Name | Target Cells | Target Tissue | Disease Area | Target Indication | Stage | Status | All
Exa1 | Apolipoprotein C III (C3) | [NAME] | Liver | Metabolic Disease | Dislipidemia / CVD | PC4 | Active | All
Exa2 | FMS-like tyrosine kinase 3 | Leukemic cells | Not defined | Oncology | AML | Identification | Identification | All
Exa3 | Anaplastic lymphoma kinase | Not defined | Not defined | Oncology | Not defined | Identification | Identification | All
Exa4 | Apolipoprotein J | Not defined | Not defined | Oncology | Not defined | Identification | Identification | All
Exa5 | B-cell lymphoma 2 | Not defined | Not defined | Oncology | Not defined | Identification | Identification | All
Exa6 | cyclin-dependent kinases | Not defined | Not defined | Oncology | Not defined | Identification | Identification | All
Exa7 | Human Epidermal growth factor Receptor 2 | Not defined | Not defined | Oncology | Not defined | Identification | Identification | All
Exa8 | inhibitors of apoptosis | Not defined | Not defined | Oncology | Not defined | Identification | Identification | All
Exa9 | [NAME] minute 2 | Not defined | Not defined | Oncology | Not defined | Identification | Identification | All
Exa10 | Serine/threonine-protein kinase B-Raf | Not defined | Not defined | Oncology | Not defined | Identification | Identification | All
Exa11 | Not defined | Not defined | Not defined | Oncology | Not defined | Identification | Identification | All
Exa12 | Not defined | Not defined | Not defined | Oncology | Not defined | Identification | Identification | All
Exa13 | Not defined | Not defined | Not defined | Oncology | Not defined | Identification | Identification | All
Exa14 | Insulin-like growth factor | Not defined | Not defined | Oncology | Not defined | Identification | Identification | All
Exa15 | phosphoinositide 3-kinase | Not defined | Not defined | Oncology | Not defined | Identification | Identification | All
Exa16 | Cytochrome P450 Oxidoreductase | Not defined | Not defined | Unclassified | Not defined | PC3 | Inactive | All
Exa17 | cytochrome P450, subfamily 2, polypeptide 11 | Not defined | Liver | Not defined | Not defined | Identification | Active (partner) | All
Exa18 | cytochrome P450, subfamily 2, polypeptide 11 | Not defined | Liver | Not defined | Not defined | Identification | Active (partner) | All
Exa19 | matrix metalloproteinase 9 | Immune Cells | Immune System | Metabolic Disease | CVD | Identification | Identification | All
Exa20 | MCP-1 receptor | Immune Cells | Immune System | Metabolic Disease | CVD | Identification | Identification | All
Exa21 | monocyte chemoattractant protein (MCP)-1 | Immune Cells | Immune System | Metabolic Disease | CVD | Identification | Identification | All
Exa22 | P-selectin | Immune Cells | Immune System | Metabolic Disease | CVD | Identification | Identification | All
Exa23 | toll-like receptor 4 | Immune Cells | Immune System | Metabolic Disease | CVD | Identification | Identification | All
Exa24 | tumour necrosis factor-α | Immune Cells | Immune System | Metabolic Disease | CVD | Identification | Identification | All
Exa25 | beta3Gal-transferase 4 | Not defined | Not defined | Metabolic Disease | CVD | Identification | Identification | All
Exa26 | cartilage intermediate layer protein 2 | Not defined | Not defined | Metabolic Disease | CVD | Identification | Identification | All
Exa27 | Apolipoprotein C-I | Not defined | Not defined | Metabolic Disease | Dislipidemia / CVD | Identification | Identification | All
Exa28 | [NAME] | Endothelial Cells | Endothelium | Metabolic Disease | Metabolic Syndrome | Identification | Identification | All
Exa29 | fatty acid binding protein (aP2) | Immune Cells | Immune System | Metabolic Disease | Metabolic Syndrome | Identification | Identification | All
Exa30 | GalNAc-transferase 2 | Not defined | Not defined | Metabolic Disease | Metabolic Syndrome | Identification | Identification | All
Exa31 | Tetratricopeptide repeat domain 39B | Not defined | Not defined | Metabolic Disease | Metabolic Syndrome | Identification | Identification | All
Exa32 | microsomal triglyceride transfer protein | [NAME] | Liver | Metabolic Disease | Dislipidemia / CVD | Identification | Identification | All
Exa33 | Cholesteryl ester transfer protein | [NAME] | Liver | Metabolic Disease | Dislipidemia / CVD | Identification | Identification | All
[NAME] | 3-hydroxy-3-methylglutaryl-Coenzyme A reductase | [NAME] | Liver | Metabolic Disease | Dislipidemia / CVD | Identification | Identification | All
Exa35 | matrix metalloproteinase-7 | Liver Cancer Cells | Liver | Oncology | HCC | Identification | Identification | All
Exa36 | Myb-related protein B (v-myb myeloblastosis viral oncogene homolog (avian)-like 2) | Liver Cancer Cells | Liver | Oncology | HCC | Identification | Identification | All
Exa37 | [NAME]-like protein | Liver Cancer Cells | Liver | Oncology | HCC | Identification | Identification | All
Exa38 | Transcription factor E2F1 | Liver Cancer Cells | Liver | Oncology | HCC | Identification | Identification | All
Exa39 | Transcription factor [NAME] | Liver Cancer Cells | Liver | Oncology | HCC | Identification | Identification | All
Exa40 | Not defined | Not defined | Not defined | Oncology | CML | Identification | Identification | All
Exa41 | deoxyhypusine hydroxylase | Liver Cancer Cells | Liver | Oncology | HCC | Identification | Identification | All
Exa42 | deoxyhypusine synthase | Liver Cancer Cells | Liver | Oncology | HCC | Identification | Identification | All
Exa43 | Not defined | Not defined | Lung | Oncology | Lung cancer | Identification | Identification | All
Exa44 | divalent metal transporter 1 | duodenal enterocytes | GI | Metabolic Disease | Hemochromatosis | Identification | Identification | All
Exa45 | transforming growth factor-beta | Not defined | Liver | Metabolic Disease | Liver fibrosis | Preclinical Nomination | Identification | All
Exa46 | Not defined | Not defined | Not defined | Metabolic Disease | Peripheral Arterial Disease | Identification | Identification | All
Exa47 | Not defined | Not defined | Not defined | Metabolic Disease | Peripheral Arterial Disease | Identification | Identification | All
Exa48 | Not defined | Not defined | Liver | Metabolic Disease | Liver Fibrosis | Preclinical Nomination | Identification | All
Exa49 | Acetyl-CoA-Carboxylase | Not defined | Not defined | Metabolic Disease | NAFLD/NASH | Preclinical Nomination | Identification | All
Exa50 | JNK [NAME] | Not defined | Not defined | Metabolic Disease | NAFLD/NASH | Preclinical Nomination | Identification | All
Exa51 | Pregnane-x-receptor | Not defined | Not defined | Metabolic Disease | NAFLD/NASH | Preclinical Nomination | Identification | All
Exa52 | Steroyl-CoA Desaturase-1 | Not defined | Not defined | Metabolic Disease | NAFLD/NASH | Preclinical Nomination | Identification | All
Exa53 | various | Not defined | Not defined | Metabolic Disease | NAFLD/NASH | Preclinical Nomination | Identification | All
Exa54 | Filovirus | Hep, RES, Immune | Liver | Infectious Disease | [NAME] | Drug Development Candidate | Active | All
Exa55 | Filovirus | Hep, RES, Immune | Not defined | Infectious Disease | [NAME] | PC4 | Active | All
Exa56 | Arenavirus | Hep, RES, Immune | Not defined | Infectious Disease | [NAME] | PC4 | Active | All
Exa57 | interferon regulatory factor 5 | Macrophage | Immune System | Inflammation | TBD | Identification | Active | All
Exa58 | Polo-like kinase | [NAME] | Not defined | Oncology | Solid tumors | Clinical Candidate | Active | All
Exa59 | Neogenin 1 | [NAME] | Liver | Metabolic Disease | Anemia of Inflammation | Identification | Identification | All
Exa60 | Prolyl hydroxylase domain | Not defined | Liver | Metabolic Disease | Anemia of Inflammation | Identification | Identification | All
Exa61 | Exostosin-like 2 | Not defined | Liver | Metabolic Disease | Diabetes | Identification | Active (partner) | All
Exa62 | Zinc-fingers and homeoboxes 2 | Not defined | Liver | Metabolic Disease | Dislipidemia | Identification | Active (partner) | All
Exa63 | Not defined | Not defined | Not defined | Oncology | Not defined | Identification | Identification | All
Exa64 | Bruton's tyrosine kinase | B cells | Immune system | Oncology | B cell malignancies (NHL, CLL) | Identification | Identification | All
Exa65 | X-linked inhibitor of Apoptosis | [NAME] | Not defined | Oncology | TBD | PC4 | Cut | All
Exa66 | Phospoenolpyruvate | Not defined | Liver | Metabolic Disease | Diabetes | Identification | Identification | All
Exa67 | microRNA-33 | Not defined | Liver | Metabolic Disease | Dislipidemia / CVD | Identification | Identification | All
Exa68 | carbohydrate responsive element–binding protein | Not defined | Liver | Metabolic Disease | Hepatic steatosis / Metabolic Syndrome | Identification | Identification | All
Exa69 | Protein kinase C epsilon | [NAME] | Liver | Metabolic Disease | NAFLD/ Type 2 Diabetes | Identification | Identification | All
Exa70 | Peroxisome-proliferator-activated receptor- co-activator-1 | Not defined | Liver | Metabolic Disease | Metabolic Syndrome | Identification | Identification | All
[NAME] | [NAME] 1c | Not defined | Liver | Metabolic Disease | Metabolic Syndrome / NAFLD | Identification | Identification | All
Exa72 | Human hemochromatosis protein | [NAME] | Liver | Metabolic Disease | Anemia of Inflammation | Identification | Identification | All
Exa73 | Factor VII | [NAME] | Liver | I.D. and Metabolic Disease | [NAME] | PC4 | Active | All
Exa74 | Tissue Factor | monocytes, fibroblasts | Immune System | Infectious D, Inflammation | [NAME] | PC4 | Active | All
Exa75 | CSN5 | [NAME] | Not defined | Oncology | HCC | Alnylam request pending | Active | All
Exa76 | wee1 (nuclear cell cycle kinase) | [NAME] | Not defined | Oncology | HCC | Alnylam request pending | Active | All
Exa77 | Constitutive photomorphogenic 1 | [NAME] | Not defined | Oncology | TBD | PC4 | Active | All
Exa77 | cyclin-dependent kinase-4 | [NAME] | Not defined | Oncology | TBD | PC4 | Active | All
Exa77 | Histone deacetylase-2 | [NAME] | Not defined | Oncology | TBD | Commercial Feasibility | Active | All
Exa77 | RING-box protein 1 | [NAME] | Not defined | Oncology | TBD | PC3 | Active | All
Exa77 | Not defined | [NAME] | Liver | Infectious Disease | HCV | PC2 | Active | All
Exa82 | Hemojuvelin (HJV) | [NAME] | Liver | Metabolic Disease | Anemia of Inflammation | PC4 | Inactive | All
Exa83 | Transferrin receptor 2 | [NAME] | Liver | Metabolic Disease | Anemia of Inflammation | PC4 | Active | All
Exa84 | connective tissue growth factor | Stellate Cell | Liver | Metabolic Disease | Liver Fibrosis | PC4 | Active | All
Exa85 | Heat shock protein 47 | Stellate Cell | Liver | Metabolic Disease | Liver Fibrosis | PC4 | Active | All
Exa86 | Not defined | [NAME] | Not defined | Oncology | TBD | PC1 | Active | All
Exa87 | Not defined | [NAME] | Liver | Infectious Disease | HBV | PC4 | Inactive | All
Exa88 | interleukin-1 receptor-associated kinase 4 | Immune Cells | Immune System | Inflammation | Liver Fibrosis/Other? | PC2 | Active | All
[NAME] | Tumor Necrosis Factor | Immune Cells | Immune System | Inflammation | TBD | PC4 | Active | All
Exa90 | Reverse erb-alpha | Not defined | Liver | Metabolic Disease | Diabetes | Identification | Active (partner) | All
Exa91 | Angiopoietin-like protein 3 | [NAME] | Liver | Metabolic Disease | Dislipidemia / CVD | Identification | Identification | All
Exa92 | Angiopoietin-like protein 4 | [NAME] | Liver | Metabolic Disease | Dislipidemia / CVD | Identification | Identification | All
Exa93 | Carbohydrate response element-binding protein | [NAME] | Liver | Metabolic Disease | Dislipidemia / CVD | Identification | Identification | All
Exa94 | [NAME] nuclear factor 4 | Not defined | Liver | Metabolic Disease | Diabetes | PC3 | Inactive | All
Exa95 | 11Beta-Hydroxysteroid Dehydrogenase Type 1 | Not defined | Liver | Metabolic Disease | Metabolic Syndrome | PC3 | Inactive | All
Exa96 | Protein phosphatase 1-beta | Not defined | Liver | Metabolic Disease | CVD | PC3 | Inactive | All
Exa97 | Retinol binding protein 4 | Not defined | Liver | Metabolic Disease | Diabetes | PC3 | Inactive | All
Exa97 | Peroxisome Proliferator-activated Receptor | Not defined | Liver | Metabolic Disease | Metabolic Syndrome | PC3 | Inactive | All
Exa97 | Glucokinase | Not defined | Liver | Metabolic Disease | Diabetes | PC3 | Inactive | All
Exa100 | Glucokinase regulatory protein | Not defined | Liver | Metabolic Disease | Diabetes | PC3 | Inactive | All
Exa101 | Inducible Degrader of the LDLR | Not defined | Liver | Metabolic Disease | Dislipidemia / CVD | PC3 | Inactive | All
Exa102 | [NAME] A desaturase 1 | Not defined | Liver | Metabolic Disease | Metabolic Syndrome | PC3 | Inactive | All
Exa103 | Phosphatase of regenerating [NAME] | [NAME] | Not defined | Oncology | TBD | Inactive | Inactive | All
Exa104 | Zinc-fingers and homeoboxes 2 | Liver Cancer Cells | Liver | Oncology | [NAME] | PC3 | Inactive | All
Exa105 | [NAME] rat sarcoma viral oncogene homolog | [NAME] | Not defined | Oncology | Not defined | PC3 | Inactive | All
Exa106 | 17Beta-Hydroxysteroid dehydrogenase Type 11 | Not defined | Liver | Metabolic Disease | Dislipidemia? | PC3 | Inactive | All
Exa107 | hypoxia inducible factor | Leukemic cells | Not defined | Oncology | AML | Identification | Identification | All
Exa108 | Not defined | Leukemic cells | Not defined | Oncology | AML | Identification | Identification | All
Exa109 | Not defined | Leukemic cells | Not defined | Oncology | AML | Identification | Identification | All
Exa110 | Not defined | Leukemic cells | Not defined | Oncology | AML | Identification | Identification | All
Exa111 | Henipavirus | Hep, RES, Immune | Not defined | Infectious Disease | [NAME] | Identification | Identification | All
Exa112 | Henipavirus | Hep, RES, Immune | Not defined | Infectious Disease | [NAME] | Identification | Identification | All
Exa113 | Bunyaviridae - Rift Valley Fever | Hep, RES, Immune | Not defined | Infectious Disease | [NAME] | Identification | Identification | All
Exa114 | Apolipoprotein B | [NAME] | Liver | Metabolic Disease | Hypercholesterolemia | Drug Development Candidate | Active | All
Exa115 | Bone morphogenetic protein receptor type IA | [NAME] | Liver | Metabolic Disease | Anemia of Inflammation | Preclinical Nomination | Identification | All
Exa116 | SMAD Family member 4 | [NAME] | Liver | Metabolic Disease | Anemia of Inflammation | Preclinical Nomination | Identification | All
Exa116 | [NAME] | [NAME] | Liver | Metabolic Disease | Anemia of Inflammation | PC4 | Active | All
Exa118 | apoptotic protease activating factor | Immune Cells | Immune System | Inflammation | Sepsis | Identification | Inactive | All
Exa119 | death receptor | Immune Cells | Immune System | Inflammation | Sepsis | Identification | Inactive | All
Exa120 | Fas Associated Death Domain | Immune Cells | Immune System | Inflammation | Sepsis | Identification | Inactive | All
Exa121 | hypoxia inducible factor | Immune Cells | Immune System | Inflammation | Sepsis | Identification | Inactive | All
Exa122 | macrophage migration inhibitory factor | Immune Cells | Immune System | Inflammation | Sepsis | Identification | Inactive | All
Exa123 | Triggering receptor expressed on myeloid cells | Immune Cells | Immune System | Inflammation | Sepsis | Identification | Inactive | All
Exa124 | Not defined | Immune Cells | Immune System | Inflammation | Sepsis | Identification | Inactive | All
Exa125 | nuclear receptor subfamily 2, group F, member 2 | Not defined | Liver | Metabolic Disease | Diabetes | Identification | Active (partner) | All
Exa126 | Src homology 2 domain containing inositol 5'-phosphatase-2 | Not defined | Liver | Metabolic Disease | Diabetes | Identification | Active (partner) | All
Exa127 | hydroxysteroid (17-beta) dehydrogenase 13 | Not defined | Liver | Metabolic Disease | Dislipidemia | Identification | Active (partner) | All